Q2 2024 EPS Estimates for Herbalife Ltd. (NYSE:HLF) Cut by Analyst

Herbalife Ltd. (NYSE:HLFFree Report) – Equities researchers at B. Riley cut their Q2 2024 earnings estimates for shares of Herbalife in a research note issued to investors on Thursday, May 2nd. B. Riley analyst J. Van. Sinderen now anticipates that the company will post earnings per share of $0.37 for the quarter, down from their prior estimate of $0.54. The consensus estimate for Herbalife’s current full-year earnings is $1.69 per share. B. Riley also issued estimates for Herbalife’s FY2024 earnings at $1.48 EPS and FY2025 earnings at $2.04 EPS.

Several other equities analysts have also commented on the stock. Bank of America decreased their price objective on shares of Herbalife from $10.00 to $8.00 and set an “underperform” rating for the company in a research report on Thursday, March 21st. StockNews.com raised shares of Herbalife from a “hold” rating to a “buy” rating in a research report on Friday, February 16th. Mizuho reduced their price target on shares of Herbalife from $12.00 to $10.00 and set a “neutral” rating for the company in a research report on Thursday, March 21st. Finally, DA Davidson reissued a “neutral” rating and set a $9.50 price target on shares of Herbalife in a research report on Thursday. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Herbalife currently has a consensus rating of “Hold” and a consensus price target of $10.50.

Check Out Our Latest Stock Report on HLF

Herbalife Stock Up 2.1 %

Shares of Herbalife stock opened at $9.58 on Monday. The firm has a market capitalization of $957.71 million, a P/E ratio of 6.99 and a beta of 1.24. The company has a 50 day moving average price of $8.82 and a 200 day moving average price of $11.52. Herbalife has a 52 week low of $6.68 and a 52 week high of $19.48.

Herbalife (NYSE:HLFGet Free Report) last announced its quarterly earnings data on Wednesday, May 1st. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.26 billion. Herbalife had a net margin of 2.70% and a negative return on equity of 19.97%. Herbalife’s revenue was up 3.8% on a year-over-year basis. During the same period last year, the firm posted $0.54 EPS.

Institutional Investors Weigh In On Herbalife

Institutional investors have recently added to or reduced their stakes in the stock. Iridian Asset Management LLC CT grew its stake in Herbalife by 49.1% in the 4th quarter. Iridian Asset Management LLC CT now owns 1,468,636 shares of the company’s stock valued at $22,411,000 after acquiring an additional 483,635 shares during the period. UBS Group AG boosted its stake in Herbalife by 5.6% during the 3rd quarter. UBS Group AG now owns 3,989,128 shares of the company’s stock worth $55,808,000 after purchasing an additional 209,949 shares during the last quarter. Vanguard Group Inc. boosted its stake in Herbalife by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 10,561,779 shares of the company’s stock worth $147,759,000 after purchasing an additional 43,452 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Herbalife by 9.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,742,507 shares of the company’s stock worth $24,378,000 after purchasing an additional 147,003 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC acquired a new stake in Herbalife during the 3rd quarter worth $381,000.

Insider Activity

In other news, Director Juan Miguel Mendoza bought 16,079 shares of the business’s stock in a transaction dated Tuesday, March 26th. The stock was purchased at an average cost of $9.40 per share, with a total value of $151,142.60. Following the acquisition, the director now directly owns 54,622 shares in the company, valued at $513,446.80. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, EVP Henry C. Wang purchased 2,778 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The shares were purchased at an average price of $9.30 per share, with a total value of $25,835.40. Following the purchase, the executive vice president now owns 176,194 shares of the company’s stock, valued at $1,638,604.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Juan Miguel Mendoza purchased 16,079 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The stock was bought at an average cost of $9.40 per share, for a total transaction of $151,142.60. Following the purchase, the director now directly owns 54,622 shares in the company, valued at approximately $513,446.80. The disclosure for this purchase can be found here. Insiders bought a total of 85,757 shares of company stock valued at $723,278 in the last three months. 0.94% of the stock is currently owned by corporate insiders.

About Herbalife

(Get Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Featured Articles

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.